Cleared Traditional

K220611 - SUREcore Plus Biopsy Instrument (FDA 510(k) Clearance)

Dec 2022
Decision
274d
Days
Class 2
Risk

K220611 is an FDA 510(k) clearance for the SUREcore Plus Biopsy Instrument. This device is classified as a Instrument, Biopsy (Class II - Special Controls, product code KNW).

Submitted by Uro-1, Inc. (Greensboro, US). The FDA issued a Cleared decision on December 2, 2022, 274 days after receiving the submission on March 3, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 876.1075.

Submission Details

510(k) Number K220611 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 2022
Decision Date December 02, 2022
Days to Decision 274 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code KNW - Instrument, Biopsy
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.1075

Similar Devices - KNW Instrument, Biopsy

All 11
Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System Control Module
K260365 · Devicor Medical Products, Inc. · Mar 2026
ZeniCore™ Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga x 10cm with Coaxial Introducer Kit)
K252795 · Argon Medical Devices, Inc. · Feb 2026
EnCor EnCompass™ Breast Biopsy and Tissue Removal System
K252681 · Bard Peripheral Vascular, Inc. · Dec 2025
Marquee™ Disposable Core Biopsy Instrument and Instrument Kit
K250032 · Bard Peripheral Vascular, Inc. · Jul 2025
ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)
K243945 · SurGenTec, LLC · Apr 2025
ALARA BMA Neuro Access Kit (ALARA BMAN and ALARA BMAC Kit)
K240664 · SurGenTec, LLC · Aug 2024